Walleye Trading Advisors »

Monopar Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5M 63k 54.79

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Airbnb Com Cl A (ABNB)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Johnson & Johnson (JNJ)

View all positions for Walleye Trading Advisors

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Adage Capital Partners GP
Saturn V Capital Management
Deerfield Management Company
BlackRock
Vanguard Group
ADAR1 Capital Management
Wellington Management Company
Vanguard Capital Management
Siren
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings
Alyeska Investment Group

View all funds holding Monopar Therapeutics